Radotinib - CAS 926037-48-1

Radotinib (IY-5511), and sometimes referred to by its investigational name IY5511, is a drug for the treatment of different types of Y, most notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) with resistance or intolerance of other tyrosine kinase Bcr-Abl inhibitors

Apoptosis, STAT, JAK, Bcr-Abl

Stem Cells, Angiogenesis, JAK/STAT signaling, Cytoskeletal Signaling, Tyrosine Kinase/Adaptors, Chromatin/Epigenetic, Apoptosis

925988

0.9997

C27H21F3N8O

530.5

Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cnccn3)c2)cc(c1)C(F)(F)F

-20°C

Ice Packs

Small Compound